Constitutive expression of IL-18 and IL-18R in differentiated IEC-6 cells: Effect of TNF-α and IFN-γ treatment by Kolinska, Jirina et al.




Constitutive expression of IL-18 and IL-18R in
differentiated IEC-6 cells: Effect of TNF-α and
IFN-γ treatment
Jirina Kolinska
The Academy of Sciences of the Czech Republic
Vera Lisa
The Academy of Sciences of the Czech Republic
Jessica A. Clark
Washington University School of Medicine in St. Louis
Hana Kozakova
The Academy of Sciences of the Czech Republic
Marie Zakostelecka
The Academy of Sciences of the Czech Republic
See next page for additional authors
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Kolinska, Jirina; Lisa, Vera; Clark, Jessica A.; Kozakova, Hana; Zakostelecka, Marie; Khailova, Ludmila; Sinkora, Marek; Kitanovicova,
Andrea; and Dvorak, Bohuslav, ,"Constitutive expression of IL-18 and IL-18R in differentiated IEC-6 cells: Effect of TNF-α and IFN-γ
treatment." Journal of Interferon & Cytokine Research.28,5. 287-296. (2008).
http://digitalcommons.wustl.edu/open_access_pubs/3186
Authors
Jirina Kolinska, Vera Lisa, Jessica A. Clark, Hana Kozakova, Marie Zakostelecka, Ludmila Khailova, Marek
Sinkora, Andrea Kitanovicova, and Bohuslav Dvorak
This open access publication is available at Digital Commons@Becker: http://digitalcommons.wustl.edu/open_access_pubs/3186
JOURNAL OF INTERFERON & CYTOKINE RESEARCH 28:287–296 (2008)
© Mary Ann Liebert, Inc.
DOI: 10.1089/jir.2006.0130
Constitutive Expression of IL-18 and IL-18R in Differentiated
IEC-6 Cells: Effect of TNF- and IFN- Treatment
JIRINA KOLINSKA,1 VERA LISA,1 JESSICA A. CLARK,2,3 HANA KOZAKOVA,4
MARIE ZAKOSTELECKA,1 LUDMILA KHAILOVA,2 MAREK SINKORA,4
ANDREA KITANOVICOVA,4 and BOHUSLAV DVORAK2
ABSTRACT
The multifunctional cytokine interleukin-18 (IL-18) is an important mediator in intestinal inflammatory pro-
cesses. The aim of this study was to evaluate the constitutive expression of IL-18 and its receptors (IL-18R
and IL-18R) in intestinal epithelial cells (IEC) stimulated by tumor necrosis factor- (TNF-) and inter-
feron- (IFN-). In addition, cellular proliferation and evaluation of brush border enzymes as differentiation
markers were studied. Nontransformed rat intestinal epithelial IEC-6 cells were grown on an extracellular
matrix (ECM) in medium with or without TNF-, IFN-, or a combination of both. Gene expression of IL-
18, its receptors and apoptotic markers was evaluated using real-time PCR. Expression of IL-18R protein
was demonstrated by flow cytometry and Western blot. Enzymatic activities of brush border enzymes and
caspase-1 were determined. The constitutive expression of IL-18, IL-18R and IL-18R mRNAs and proteins
were detected in IEC-6 cells. The biologically active form of IL-18 was released in response to TNF- and
IFN- treatment. Exogenous IL-18 had no effect on cellular proliferation, brush border enzyme activities, and
gene expression of apoptotic markers. However, the addition of IL-18 stimulated production and release of




INTERLEUKIN-18 (IL-18) is a multifunctional cytokine withstructural similarities to the IL-1 cytokine family (Okamura
and others 1995b; Nakanishi and others 2001). Initially, IL-18
was described as an interferon- (IFN-)-inducing factor in
mice infected with Propionibacterium acnes (Okamura and oth-
ers 1995a). Later, it was found that IL-18 is detectable in dif-
ferent cell types, including macrophages, keratinocytes (Stoll
and others 1997), osteoblasts (Udagawa and others 1997), car-
diomyocytes (Chandrasekar and others 2003), rat testis (Strand
and others 2005), and epithelial cells (Takeuchi and others
1997). IL-18 is produced as a precursor molecule, which is
cleaved by caspase-1 to the mature, bioactive protein (Gu and
others 1997) capable of activating the IL-18 receptor complex
(Torigoe and others 1997). Although the biologic functions of
IL-18 are still not fully understood, IL-18 is considered to be
an important factor in the regulation of inflammatory processes
(Reuter and Pizarro 2004).
Intestinal epithelial cells (IECs) line the mucosal surface of
the intestine and, in addition to their digestive and absorptive
functions, form a barrier to prevent the entry of microbes and
antigens into the underlying tissue (Goodrich and McGee 1998).
IECs can constitutively, or upon stimulation, produce a num-
ber of cytokines, chemokines, and growth factors that play an
important role in mucosal immune response (Stadnyk 2002).
IECs possess receptors that respond to extrinsic stimuli, such
as intestinal infection and cytokines produced by activated im-
mune cells. Specific cytokines, such as IFN- and tumor ne-
crosis factor- (TNF-), alone (Kaiser and Polk 1997; Chavez
and others 1999) or in synergy (Fish and others 1999), may al-
ter enterocyte activity, proliferation, differentiation, and in-
testinal barrier function (Snoeck and others 2005). Epithelial
cell lines cultured with cytokines have been used successfully
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as an in vitro model for studying inflammatory processes
(Vallee and others 2004).
Proinflammatory cytokines have been implicated in the
pathogenesis of inflammatory bowel disease due to their over-
production in inflamed mucosa (Breese and others 1994; Sar-
tor 1994; Niessner and Volk 1995). In the presence of proin-
flammatory IFN-, precursor T cells are polarized toward a Th1
phenotype. Activation of Th1 cells induces an inflammatory
cascade that is associated with the production of TNF- by mac-
rophages and lymphocytes. Many lines of evidence suggest that
IL-18 (Pages and others 2000) plays a central role in inflam-
matory diseases by acting on Th1 cell differentiation and al-
tering the cytokine profile. In patients with Crohn’s disease
(Pizarro and others 1999), chronic lesions exhibit increased 
IL-18 protein levels accompanied by overproduction of IL-18-
induced cytokines, such as IFN-, IL-1, IL-8, and TNF-. The
presence of these cytokines promotes neutrophil infiltration,
leading to tissue injury. Similarly, in experimental models of
intestinal injury (Siegmund and others 2001; Halpern and oth-
ers 2002), overproduction of IL-18 in the inflamed mucosa is
correlated with progression of tissue damage. Interestingly, 
IL-18 is produced not only by various immunocompetent cells
but also by the IECs in both normal and inflamed mucosa
(Takeuchi and others 1997; Halpern and others 2002; Kalina
and others 2002; Okazawa and others 2004). However, the
physiologic role of epithelial cell-derived IL-18 remains unclear
(Okazawa and others 2004).
In this study, the nontransformed rat IEC derived from rat
small intestine (Quaroni and others 1979) was used. To study
expression of IL-18 and its receptors (IL-18R and IL-18R),
we used the nontransformed rat IEC line IEC-6 cultivated on
an artificial extracellular matrix (ECM) (He and others 1993),
producing differentiated villuslike cells that are more suscepti-
ble to apoptosis and cell injury. Such cells were used to eluci-
date the mechanisms of cytokine action on differentiated cells.
The aim of this study was to evaluate the constitutive expres-
sion of IL-18, IL-18R, and IL-18R mRNAs, IL-18R, and
IL-18 proteins in IEC-6 cells modulated with TNF- and 
IFN-. In addition, cellular proliferation and differentiation, as-
sessed by levels of brush border enzymes, were evaluated.
MATERIALS AND METHODS
Cell line, cytokines, and reagents
IEC-6 cells were purchased from American Type Culture
Collection (ATCC, CRL-1592, Manassas, VA). Recombinant
rat TNF- was from Serotec (Kidlington, UK), and recombi-
nant rat IFN-, recombinant rat IL-18, and goat antimouse IL-
18R were from R&D Systems, Inc. (Minneapolis, MN). Rat
IL-18 ELISA kit was purchased from Biosource International
(Nivelles, Belgium). Caspase-1 Colorimetric Assay Kit was
provided by BioVision Inc. (THP Medical Products, Vienna,
Austria). EMC Gel, CHAPS, pepstatin A, five nucleotide
monophosphates (AMP, CMP, IMP, GMP, and UMP), DMEM
medium, insulin and 5-bromo-4-chloro-3-indolyl phosphate/ni-
tro blue tetrazolium were purchased from Sigma (St. Louis,
MO). Glycyl-L-proline-4-nitroanilide was from Sigma-Aldrich
(Diesenhofen, Germany). Zwittergent 3–14 was obtained from
Calbiochem (La Jolla, CA). Gentamicin was from Krka (Ljubl-
jana, Slovenia). Rabbit antigoat IgG conjugated with FITC and
rabbit anti-goat IgG conjugated with alkaline phosphatase were
from Vector Laboratories (Burlingame, CA), and 5-L-glutamic
acid-4-nitroanilide, p-nitrophenylphosphate, and glycylglycine
were from Fluka (Buchs, Switzerland).
IEC-6 cultures
Normal rat small intestinal IEC-6 cells (15–27 passages)
were used. The stock culture was grown in DMEM at 37°C,
95% air and 5% CO2. The medium contained 40 g/mL gen-
tamicin, 2 mM glutamine, 50 mL/L fetal bovine serum (FBS),
and 10 mg/L insulin. For experiments, the cells were plated at
a density of 1.6  106/cm2 onto plastic plates (60 mm in di-
ameter) coated with Matrigel (Engelbreth-Holm-Swarm sar-
coma basement membrane). The cultivation medium contained
a mixture of five nucleotide monophosphates (10 mg/L each),
added on the second day after seeding (He and others 1993).
At day 5, the culture medium was replaced with fresh medium
containing the nucleotide mixture and either TNF-, IFN-, or
a combination of both. In some experiments, IL-18 was added.
On day 8, the culture medium was removed and stored at
75°C. The cells were harvested by gentle trypsinization with
0.25% trypsin-0.3% EDTA. Cells were washed with phosphate-
buffered saline (PBS) and directly used for flow cytometry or
pelleted at 10,000g and homogenized in (1) 0.6 mL lysis buffer
RLT for RNA isolation, stored at 75°C, (2) 50 mM KCl for
enzyme assays, centrifuged at 100,000g for 45 min, and the pel-
let solubilized in 0.5% Zwittergent 3–14 in 50 mM KCl at 4°C
for 2 h and centrifuged at 100,000g for 45 min, the supernatant
stored at 75°C, or (3) 0.6 mL lysis buffer for caspase-1 as-
say, centrifuged at 100,000g for 45 min, and the supernatant
stored at 75°C.
RNA preparation
Total RNA was isolated from IEC-6 cells using the RNeasy
Mini Kit (Qiagen, Santa Clara, CA) as described in the manu-
facturer’s protocol and our previous studies (Halpern and oth-
ers 2003; Clark and others 2005). All samples were incubated
with RNase-free DNase (20 U per reaction) for 10 min at 37°C
to eliminate DNA contamination. RNA concentration was quan-
tified by ultraviolet spectrophotometry at 260 nm, and the pu-
rity was determined by the A260/A280 ratio (SPECTRAmax
PLUS, Molecular Devices, Sunnydale, CA). The integrity of
RNA was verified by electrophoresis on a 1.2% agarose gel
containing formaldehyde (2.2 M) and ethidium bromide in 1 
MOPS buffer (40 mM MOPS, pH 7.0, 10 mM sodium acetate,
and 1 mM EDTA, pH 8.0) (Halpern and others 2003; Clark and
others 2005).
RT and real-time PCR
RT real-time PCR assays were performed to quantify rat 
IL-18, IL-18R, IL-18R, Bcl-2, and Bax steady-state mRNA
levels (Halpern and others 2002, 2003; Clark and others 2005).
cDNA was synthesized from 0.5 g DNase-treated total RNA.
Target (Bcl-2, Bax, IL-18R, and IL-18R) primers and probes
were designed using Primer Express Software™ (Applied
Biosystems, Foster, CA) (Table 1). Target probes were labeled
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with fluorescent reporter dye FAM (Pham and others 2003).
Predeveloped TaqMan® primer and probe were used for de-
tection of IL-18 (Applied Biosystems). Reporter dye emission
was detected by an automated sequence detector combined with
ABI Prism 7700 Sequence Detection System® software (Ap-
plied Biosystems). Real-time PCR quantification was then per-
formed using TaqMan 18S controls. Relative quantification of
PCR products was based on value differences between the tar-
get and 18S control using the comparative CT method (Menon
and others 2001). Cycle parameters were 55°C for 5 min, 95°C
for 10 min, and then 40 cycles of 95°C for 15 sec, 55°C for 60
sec. All samples were run in triplicate for each PCR reaction.
Flow cytometry
Cultured IEC-6 cells were washed twice in cold PBS con-
taining 0.1% sodium azide and 0.2% gelatin (PBS-GEL) and
were surface stained for flow cytometry as described previously
(Sinkora and others 2005, 2007). Briefly, cells were incubated
with goat antimouse IL-18R primary polyclonal antibody for
30 min and subsequently washed twice in PBS-GEL. This an-
tibody was shown to cross-react with rat IL-18R (Chandrasekar
and others 2003). In control staining, primary antibody was re-
placed by PBS-GEL alone, by normal heat-inactivated goat
serum, or by goat antimouse IgG polyclonal antibody. Rabbit
antigoat IgG secondary antibody conjugated with FITC was
then added to the cell pellets, and after 30 min, cells were
washed three times in PBS-GEL and measured on a FACS
Calibur cytometer (BDIS, Mountain View, CA). Damaged and
dead cells were excluded from analysis using propidium iodide
fluorescence.
Cytokine protein measurements
IL-8 and monocyte chemotactic protein 1 (MCP-1) were
measured using a Luminex-based bead array method using the
LINCOplex simultaneous multianalyte detection system for rats
(Linco Research, Inc., St. Charles, MO) following the manu-
facturer’s instructions. The cytokines were simultaneously mea-
sured in cultivation medium from each sample. The concentra-
tion of IL-18 protein in the cultivation medium was determined
using the enzyme-linked immunosorbent assay (ELISA) kit for
rat IL-18 according to the manufacturer’s instructions
(Biosource International).
Caspase-1 assay
Pelleted IEC-6 cells were homogenized in lysis buffer con-
taining 25 mM Na HEPES, 2 mM DTT, 1 mM EDTA, 0.1%
CHAPS, 10% sucrose, 1 mM PMSF, and 1 M pepstatin A,
pH 7.2. The lysate was centrifuged at 4°C at 100,000g. The su-
pernatant was immediately frozen and stored at 75°C until
use. The assay was performed using the caspase-1 colorimetric
assay kit according to the manufacturer’s instructions (BioVi-
sion Inc.). Caspase-1 activity was expressed in nanomoles/g
protein. Protein measurement was with Folin phenol reagent.
Western blot
Cells were extracted with lysis buffer containing 2 mM
EDTA, 50 mM TRIS-HCl, pH 7.5, 100 mM NaCl, and 1% Non-
idet 40. After centrifugation at 15,000g, supernatants were used
for further analysis. Cell lysates were diluted in 10 mM KCl to
obtain a final concentration of 2 mg/mL protein. The same vol-
ume of each lysate (20 L/well) was subjected to 10% SDS-
polyacrylamide gel electrophoresis (PAGE) under reducing
conditions and transferred onto nitrocellulose membranes. 
IL-18 R was detected after incubation of membranes with goat
antimouse IL-18R antibodies (1:500 final dilution), followed
by incubation with rabbit antigoat IgG conjugated with alka-
line phosphatase (1:500 final dilution). Immunoreactive bands
were visualized using 5-bromo-4-chloro-3-indolyl phosphate/
nitro blue tetrazolium. Quantification of IL-18R expression
was performed using dot-blot analysis. Densitometry was per-
formed to compare protein expression between groups with Bio-
Rad QuantityOne software (Richmond, VA).
Determination of IEC-6 brush border enzymes
Lactase of the lactase-phlorizinhydrolase complex (-galac-
tosidase, glycosylceramidase; EC 3.2.1.23/62/108), sucrase (EC
3.2.1.48) of the sucrase-isomaltase complex (sucrose -glucosi-
dase, oligo-1,6-glucosidase; EC 3.2.1.48/10), and glucoamylase
of the maltase-glucoamylase complex (-glucosidase, glucan 1,4-
-glucosidase; EC 3.2.1.20/3) activities were determined with 50
mM lactose, 50 mM sucrose, and 12 g/L starch as substrates, re-
spectively (Kolinska and Kraml 1972; Kraml and others 1972).
The liberated glucose was measured with the Tris-glucose oxi-
dase-peroxidase reagent (Dahlqvist 1964). Alkaline phosphatase
(ALP) (EC 3.1.3.1), activity was determined in brush border mem-
brane vesicles (BBMV) with 0.1 M p-nitrophen-ylphosphate as
substrate in Tris-HCl buffer, pH 8.5. The liberated p-nitrophenol
was measured at A405 using the Test Kit (Lachema, Brno, Czech
Republic). The activity of -glutamyltranspeptidase (GGT; EC
2.3.2.2) was determined with 7 mM 5-L-glutamic acid-4-ni-
troanilide as donor substrate, 0.1 mol/L glycylglycine, pH 8.2, as
acceptor substrate, and 0.1 M NaCl as activator. Released 4-ni-
troaniline was measured at A405 (Thompson and Meister 1976).
The activity of dipeptidyl peptidase IV (DPP IV; EC 3.4.14.5)
was determined with 1.4 mM glycyl-L-proline-4-nitroanilide in 66
mM Tris-HCl buffer, pH 8.0. The reaction was stopped with 1 M
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TABLE 1. SEQUENCES OF PCR PRIMERS AND PROBES
Gene Sense primer Antisense primer Probe sequence GenBank
Bcl-2 aggattgtggccttctttgagtt gccggttcaggtactcagtcat ccctggtggacaacatcgctct N016993.1
Bax ttgctgatggcaacttcaactg ctttagtgcacagggccttgag ccgcgtggttgccctcttctactttg NM017059.1
IL-18R ctcaatgttttatataattgtaccgtggc ccttggatgtcaggtgtttcttttc aacgaagaagccacagacac XM237088.4
IL-18R ctttctctgtctctcagaggcc gaggcttaacttccaagacagtct acacaacaagctgtatcctg AJ550893.1
sodium acetate buffer, pH 4.2, and the released 4-nitroaniline was
measured at A405 (Nagatsu and others 1976). Enzyme activities
were expressed as nkat/mg protein, 1 nanokatal being the amount
of the enzyme that converts 1 nanomole of substrate per second
under the given conditions. Protein was estimated with Folin phe-
nol reagent.
Statistics
Statistical analyses between groups were performed using
analysis of variance (ANOVA) followed by Fisher protected
least significant difference. All statistical analyses were deter-
mined using the statistical program StatView (Abacus Con-
cepts, Berkeley, CA). All numerical data are expressed as
mean  SEM. Statistical analysis of brush border enzymes was
assessed by nonparametric ANOVA Kruskal-Wallis test, fol-
lowed by pairwise group comparison using the Mann-Whitney
U-test. The data are expressed as mean  SD.
RESULTS
TNF-  IFN- induce changes in IEC-6 cell number
Table 2 shows there was no change in cell number when
monolayers plated on Matrigel were cultivated with either 10
or 20 ng/mL TNF-. Proliferation of IEC-6 cells was markedly
inhibited by IFN- at concentrations of 100 and 200 ng/mL.
When added together, TNF- (20 ng/mL) intensified the effect
of IFN- (100 ng/mL).
TNF- in combination with IFN- significantly
inhibits expression of differentiation marker enzymes
Table 3 shows that TNF- (20 ng/mL) did not affect the ex-
pression of any brush border enzyme studied. In contrast, 
IFN- (100 ng/mL) significantly inhibited expression of the
main membrane differentiation markers lactase, sucrase, and
glucoamylase. TNF- in combination with IFN- markedly in-
hibited the expression of both glycosidases and peptidases and,
to the greatest extent, alkaline phosphatase.
Detection of IL-18 mRNA by real-time RT-PCR
IL-18 mRNA was detectable in nontransformed rat IEC-6
cells plated on a basement membrane matrix and cultured in
DMEM-based medium supplemented with insulin and five nu-
cleotide monophosphates (Fig. 1). No significant changes in 
IL-18 mRNA expression were found after addition of TNF-
(20 ng/mL) or IFN- (60 ng/mL) to the cultivation medium on
day 5 until harvest. Stimulation of IEC-6 cells with a combi-
nation of both TNF- and IFN- (20 ng/mL and 60 ng/mL, re-
spectively) caused a significant decrease in IL-18 mRNA com-
pared with control.
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TABLE 2. EFFECT OF TNF- AND IFN- ON IEC-6 CELL COUNTSa
Treatment
no. Control 10 ng/mL 20 ng/mL 100 ng/mL 200 ng/mL 100 ng/mL  20 ng/mL
1 5.13  2.21 4.53  0.19*
2 5.95  0.11 5.88  0.21
3 5.17  0.14 3.95  0.11***
4 4.97  0.30 3.02  0.40*
5 5.68  0.05 3.32  0.05***
aValues are means  SEM, represent cell counts  106/60-mm plastic plate. IEC-6 (1.3  106/cm2) passages 15–27 were
plated onto the Matrigel-coated plastic plates in DMEM-based medium with nucleotide mixture. Addition of cytokines on culti-
vation day 5; cells collected on day 8.
*p  0.05; ***p  0.001 vs. control.
TNF- IFN- IFN-  TNF-
TABLE 3. EFFECT OF TNF- (20 NG/ML) AND IFN- (100 NG/ML) ON ENZYME ACTIVITIES OF MEMBRANE FRACTION OF IEC-6a
TNF-
Enzyme Control IFN- nkat/mg protein ( 103) IFN-  TNF-
Lactase 106.4  6.4 78.0  12.0** 107.6  15.7 31.0  9.7**
Sucrase 27.1  1.3 16.3  5.9* 23.8  11.5 6.9  5.3**
Glucoamylae 85.5  4.3 63.3  18.8* 91.3  23.8 21.7  6.7**
DPP IVb 440  25 413  53 440  31 307  43**
GGT 225  17 217  32 227  21 129  76**
Alkaline phosphatase 96.9  6.9 86.8  9.4 97.4  11.9 8.4  1.2**
aValues presented as means  SD. IEC-6 (1.3  106/cm2) passages 18–25 grown on the Matrigel matrix in DMEM-based
medium with nucleotide mixture. Addition of cytokines on cultivation day 5; cells collected on day 8.
bDPP IV, dipeptidyl peptidase IV; GGT, -glutamyltranspeptidase.
*p  0.05; ***p  0.01 for cytokine-treated cells vs. control.
Effects of TNF- and IFN- on secretion of IL-18
protein from IEC-6 cells
IEC-6 cells secrete IL-18 protein into the cultivation medium
without any stimulation. Cells grown in cultivation medium
supplemented with either TNF- or IFN- alone or a combi-
nation of both significantly increased the secretion of IL-18 pro-
tein (Fig. 2). Because of a variation in the IL-18 concentration
in supernatants from individual subcultures, combined results
from all studies are expressed as mean relative IL-18 levels.
The range of the actual IL-18 concentrations expressed in
pg/million cells was: control (1–10), IFN- (3–26), TNF-
(8–18), and IFN  TNF (19–36).
Detection of IL-18R and IL-18R mRNAs by 
real-time RT-PCR
Stimulation of IEC-6 cells with IFN- caused increased ex-
pression of IL-18R, whereas TNF- or the combination of
both did not have any stimulatory effect on IL-18R mRNA
level (Fig. 3A). In contrast, gene expression of IL-18R was
not affected by IFN- or TNF- alone; however, the combina-
tion of both cytokines caused synergistic stimulation of 
IL-18R expression (Fig. 3B).
Constitutive expression of IL-18R protein and its
detection on surface of cells
Because an antibody against rat IL-18R is not available, we
used antimouse IL-18R that was shown to cross-react with rat
IL-18R (Chandrasekar and others 2003). Constitutive expres-
sion of IL-18R protein was shown in IEC-6 cells after 8 days
in culture. IEC-6 lysate resolved on SDS-PAGE and probed
with antimouse IL-18R revealed three domains of IL-18R
on Western blot (Fig. 4A). This may indicate IL-18R poly-
morphisms (Azam and others 2003). In Figure 4A, lane 1 with-
out and lane 2 with 20 ng/mL TNF- added for the last 24 h
into the cultivation medium represent the first subculture. There
was no visible effect of TNF- on IL-18R expression. In the
second subculture (Fig. 4A, lane 3, control), 20 ng/mL TNF-
(lane 4) added on day 5 slightly stimulated IL-18R expression
on day 8 of IEC-6 cultivation. Lane 1 and lane 3 represent con-
trol samples of two independent cell subcultures after 8-day cul-
tivation; they differ remarkably, with much lower expression
of IL-18R in the first subculture than in the second subcul-
ture.
Flow cytometry (Fig. 4B, line A) shows that IL-18R, cor-
responding to the first subculture in Figure 4A, lane 1, was ex-
pressed on the surface of about 5%–10% of IEC-6 cells (Fig.
4B, line A). Control staining (Fig. 4B, lines B, C, and D) proved
that there is no nonspecific binding of either primary or sec-
ondary antibodies. The low percentage of IEC-6 cells that ex-
pressed IL-18R on the surface may indicate that the cells were
not synchronized in the same phase of the cell cycle. As re-
vealed on dot-blot of sequentially diluted cell samples, TNF-
or a combination of TNF- and IFN- significantly increased
the expression of IL-18R compared with IFN- (Fig. 4C)
(*p  0.05 vs. IFN-).
Caspase-1 activity in IEC-6 cells
Caspase-1 is an intracellular cysteine protease that converts
the inactive IL-18 precursor to the mature cytokine secreted into
the extracellular space (Melnikov and others 2001). Control
IEC-6 cells produced a constitutive level of active caspase-1
(50  2 pmol/g protein), which was upregulated by IFN-
(65  6 pmol/g protein, p  0.05). TNF- induced a slight
but insignificant effect on caspase-1 expression (55  7
pmol/g protein) compared with the control. These results sug-
gest that IEC-6 cells are capable of secreting mature bioactive
IL-18.
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FIG. 1. IL-18 mRNA levels were detected after stimulation
with TNF- (20 ng/mL), IFN- (60 ng/mL), and TNF-  IFN-
 20 ng/mL  60 ng/mL) for 3 days using real-time RT-PCR.
The mean mRNA levels from stimulated groups were deter-
mined relative to the control group, which was given a value
of 1.0. *p  0.05 vs. control.
FIG. 2. Secretion of IL-18 protein. TNF- (20 ng/mL),
IFN- (60 ng/mL), and TNF-  IFN- (20 ng/mL  60
ng/mL) added on day 5 of cultivation induced IL-18 protein
secretion from IEC-6 cells after 3 days in culture. IL-18 pro-
tein levels in culture supernatants were evaluated by ELISA.
The mean protein levels from stimulated groups were deter-
mined relative to the control group from each experiment.
*p  0.05 vs. control.
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FIG. 3. Gene expression of IL-18R (A) and IL-18R (B).
Messenger RNA levels were detected after stimulation with
TNF- (20 ng/mL), IFN- (60 ng/mL), and TNF-  IFN-
 (20 ng/mL  60 ng/mL) for 3 days using real-time RT-
PCR. The mean mRNA levels from stimulated groups were
determined relative to the control group. ‡p  0.05 vs. con-
trol.
FIG. 4. Constitutive expression of IL-18 R. (A) Western
blot analysis of IL-18R expression in lysates of IEC-6 cells
after 8-day cultivation. Experiment I: lane 1, control; lane 2,
TNF- (20 ng/mL) for last 24 h in cultivation medium. Ex-
periment II: lane 3, control; lane 4, TNF- (20 ng/mL) 72 h in
cultivation medium. (B) Flow cytometry detection of IL-18R
on the surface of about 5%–10% rat IEC-6 cells (A), negative
control staining with no primary antibody (B), using normal
goat serum (C), or using irrelevant goat polyclonal antibody
(D) does not show any reactivity with IEC-6 cells. The results
are representative of the subculture of low IL-18R expression
(Fig. 4A, Experiment I, lane 1). (C) Quantification of dot-blot
analysis of IL-18R expression in lysates of IEC-6 cells after
addition of TNF- (20 ng/mL), IFN- (60 ng/mL), and TNF-
  IFN- (20 ng/mL  60 ng/mL) in cultivation medium.
**p  0.05 vs. IFN-.
Detection of mRNA levels of proapoptotic and
antiapoptotic markers in IEC-6 cells
Apoptosis is an important regulatory mechanism of homeo-
stasis in the intestinal epithelium (Clark and others 2005), and
TNF- is a potent inducer of cell death (Halpern and others
2006). Gene expression of proapoptotic Bax and antiapoptotic
Bcl-2 was evaluated using RT real-time PCR (Clark and oth-
ers 2005; Halpern and others 2006). Proapoptotic Bax mRNA
levels were significantly increased in TNF- and IFN- 
TNF--treated IEC-6 cells (Fig. 5A). Treatment with IFN- or
IFN-  TNF- caused a statistically significant decrease of
Bcl-2 mRNA levels compared with TNF- treatment (Fig. 5B).
Appearance of chemokine IL-8 and MCP-1 in
cultivation medium following stimulation with IL-18
IEC-6 monolayers were stimulated with rat IL-18 on days
5–8 of cultivation. IL-8 is a marker of cellular activation and
was detected in the cultivation medium at the end of the ex-
periment. Table 4 shows significant induction of IL-8 produc-
tion and a slight increase in MCP-1 by externally administered
IL-18. Other parameters given in Table 4 were not influenced
by IL-18. We did not find any effect of TNF- and IFN- on
IL-8 protein appearance (data not shown). There were no sta-
tistically significant differences in Bax and Bcl-2 expression in
the IL-18-treated groups (Table 4).
DISCUSSION
The inflammatory processes in the intestine represent a com-
plex interplay of immune and epithelial cell interactions. In re-
cent years, IL-18 has been shown to be an important mediator
in intestinal inflammatory disorders. In the present study, we
have shown for the first time that the normal rat intestinal ep-
ithelial cell line IEC-6 constitutively expresses IL-18 and het-
erodimeric IL-18 receptors. In addition, exogenous IL-18 stim-
ulates the production and secretion of IL-8 in IEC-6 cells.
Increased gene expression and protein production of the
proinflammatory cytokine IL-18 have been shown in a rat
model of necrotizing enterocolitis (NEC) (Halpern and others
2002). In this model, the production of IL-18 is localized in the
ileal epithelium, and overproduction of IL-18 correlates with
villus damage (Halpern and others 2002). This suggests that
both intraepithelial (IEL) and IEC may play an important role
during intestinal injury and that their interactions may be reg-
ulated by IL-18. In an in vivo system, IL-18 may initiate a cas-
cade of inflammatory cytokines by cells of the immune system
that express IL-18 receptors (Puren and others 1998). These
cells include macrophages, natural killer (NK) cells, dendritic
cells, and most T cells (Eaton and others 2003). T cells isolated
from inflamed tissue in Crohn’s disease respond to IL-18 by
increasing production of IFN- (Maerten and others 2004).
To characterize the capability of small IECs to produce and
use IL-18 in the absence of immune cells, we evaluated IL-18
and IL-18R (ligand-binding chain, IL-1Rrp) and associating
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TABLE 4. EFFECT OF EXOGENOUS IL-18 ON IEC-6 CELL
COUNTS, APOPTOSIS MARKERS BAX AND BCL-2 MRNAS,
SECRETION OF CHEMOKINES (IL-8 AND MCP-1), SUCRASE,
AND ALKALINE PHOSPHATASE ACTIVITIESa
Control IL-18
Cell counts ( 106) 5.49  0.34 5.79  0.44
Relative mRNA Bax 1.00  0.09 0.82  0.04
Relative mRNA Bcl-2 1.00  0.19 0.84  0.06
IL-8 (ng/mL) 9.43  2.63 49.14  13.05*
MCP-1 (ng/mL) 1.59  0.16 2.17  0.19
Sucrase 27.1  1.3 27.5  1.2
ALP 96.9  6.9 100.6  14.8
aValues are means  SEM. IEC-6 grown on Matrigel ma-
trix in DMEM-based medium with nucleotide mixture. Addi-
tion of IL-18 (10 ng/mL) on day 5, cells collected on day 8.
Assays were performed as indicated in Materials and Methods.
Sucrase and alkaline phosphatase activities are expressed in
nkat/mg protein ( 103).
*p  0.01.
FIG. 5. Effect of IFN- (60 ng/mL), TNF- (20 ng/mL), and
TNF-  IFN- (20 ng/mL  60 ng/mL) on relative levels of
proapoptotic marker Bax mRNA (A) and antiapoptotic marker
Bcl-2 mRNA (B). The mean mRNA levels from stimulated
groups were determined relative to number 1.0 of the control
group. #p  0.01 vs. control; ¶ p  0.01 vs. TNF-.
IL-18R (signal-transducing chain/AcPL) gene expression in
the differentiated villuslike IEC-6 cell line. It is characterized
by the appearance of the differentiation markers sucrase, glu-
coamylase, and ALP, in accordance with the data of others (He
and others 1993; Wood and others 2003). Having evaluated the
effects of the lymphocyte-producing cytokines TNF- and 
IFN-, we asked the question whether TNF- and IFN- have
a direct effect on epithelial cell functions and whether they act
synergistically. Our data reveal the possibility of both types of
action. Further, the results show that costimulation with IFN-
rendered the IEC-6 cells more susceptible to TNF-. Accord-
ing to Ruemmele and others (1999) and Fish and others (1999),
this may be explained as the enhanced proapoptotic response
of TNF- by IFN- via stimulation of TNF- receptor expres-
sion. Under such conditions, we observed not only the reduc-
tion of cell number to 70% but a much higher reduction in en-
zyme activity levels, especially of ALP, which was reduced to
10%. Inhibition of ALP may indicate that the liver isoform of
ALP, known to develop in differentiated IEC-6 cells (Wood
and others 2003) and characterizing the state of differentiation,
is most sensitive to the synergistic effect of TNF- and IFN-
-mediated alterations of epithelial cell function. Depression of
sucrase activity by IFN- in IEC-6 cells could be related to a
selective downregulation of sucrase gene expression in villus
enterocytes of acutely inflamed Crohn’s ileum (Ziambaras and
others 1996).
Another example for a synergistic effect of TNF- and 
IFN- is gene expression of antiapoptotic mitochondrial pro-
tein Bcl-2 that stabilizes the mitochondrial inner transmembrane
potential and prevents opening of transition pores. In the pres-
ent study, IFN- decreased gene expression of Bcl-2, whereas
TNF- increased Bcl-2 expression. Similarly, TNF- acceler-
ated IFN--dependent changes in transepithelial resistance of a
colonic cell line (Fish and others 1999). However, IFN- does
not affect the transcript level of the proapoptotic marker Bax,
promoting mitochondrial permeability. Interestingly, TNF-
stimulated Bax gene expression without synergy with IFN-.
The final effect may represent dysregulation of the balance be-
tween proapoptotic and antiapoptotic Bcl-2 family members.
This study is the first to describe, in the absence of immune
cells, constitutive expression of IL-18 and its receptors in the
rat villus enterocyte-like IEC-6 line. Further, we showed that
IEC-6 cells constitutively produce both IL-18 protein and li-
gand-binding IL-18R protein. Investigation of culture super-
natants indicated detectable secretion of IL-18 into the culture
medium, which was stimulated by the proinflammatory cyto-
kines IFN- and TNF- that may partially mimic the presence
of a specific T cell. Although neither IFN- nor TNF- alone
is involved in gene activation of IL-18, the combined effect of
both cytokines leads to decreased IL-18 mRNA. Both cytokines
did stimulate IL-18 secretion, but this phenomenon seems to be
regulated by posttranslational mechanisms, such as extracellu-
lar export. This notion is supported by studies on dendritic cells
(Gardella and others 1999) showing that IL-18 precursor pro-
tein lacks a signal peptide and its secretion does not occur along
the classic endoplasmic reticulum-Golgi pathway.
IL-18 secretion from the intracellular compartment involves
proteolytic processing and translocation of cytosolic molecules
into secretory lysosomes (Semino and others 2005). In addi-
tion, it was reported that secretion of IL-18 requires processing
by proteolytic enzymes, particularly by caspase-1 (Fantuzzi and
others 1999). As caspase-1 activity is required for cleavage of
the precursor form of IL-18 into the mature biologically active
IL-18 (Melnikov and others 2001), we evaluated capase-1 en-
zymatic activity in this system. Our results show the presence
of the active form of caspase-1 in IEC-6 cells. Consequently,
release of IL-18 protein into the cultivation medium was de-
tected. Thus, IEC-6 cells are capable of expressing and syn-
thesizing the mature IL-18 protein. These data suggest that the
first level of regulation of IL-18 precursor protein by other cy-
tokines in IEC-6 cells is also at the nonclassic secretion step.
Indeed, upregulation of IL-18 secretion by IFN- correlated
with increased expression of the caspase-1 activity by this cy-
tokine. The ability of IFN- to induce caspase-1 activity in IEC-
6 cells correlated with its ability to cause stimulated expression
of the caspase-1 gene in the U937 leukemia cell line (Tamura
and others 1996). However, we did not observe any effect of
TNF- on caspase-1 activity and still found stimulated secre-
tion of IL-18 from IEC-6 cells. Possibly there exists another,
caspase-1-independent system of IL-18 release from the cell.
Indeed, in macrophages, Fas/Fas ligand (FasL) was suggested
(Tsutsui and others 1999) to operate in this way in caspase-1-
deficient mice. Fas and FasL are transmembrane proteins and
members of the TNF receptor family. They are also expressed
constitutively in some nonimmune cells (Choi and others 1999),
and TNF- and IFN- promote their expression. We hypothe-
size that this system might be involved in mediating IL-18 re-
lease from IEC-6 cells. As the combined addition of TNF- and
IFN- does not significantly exceed the secretion of IL-18 pro-
tein stimulated by either TNF- or IFN- alone, we expect in-
dependent effects of these cytokines.
It is known from previous studies that mature IL-18 exerts
its effects on binding to two receptor chains, IL-18R and 
IL-18R, essential for signal transduction (Kim and others
2001). Results from our studies indicate constitutive gene ex-
pression of both components of IL-18R, in contrast to some
other cell types, such as native COS-1 cells (Kim and others
2001) and rat islet -cells (Hong and others 2000) that lack
IL-18R. Our results show different regulation of IL-18R
and IL-18R by IFN- and TNF-. Expression of IL-18R
mRNA is upregulated by IFN-, but supplementation with
TNF- neutralizes this stimulatory effect. On the other hand,
neither cytokine alone affects IL-18R mRNA expression,
but additive stimulation by TNF- and IFN- occurs. How-
ever, only negligible effects of TNF- and IFN- on the ex-
pression of IL-18R protein were seen. The discrepancy be-
tween IL-18R gene and protein levels after stimulation with
IFN- suggests differences in cytokine regulation of IL-18R
expression at the transcriptional or translational level in IEC-
6 cells.
The presence of functional IL-18R in nonimmunocompe-
tent cells is required for IL-12-independent production of IL-8
(Kim and others 2001). Because of the lack of available IL-
18R antibodies, IL-18R protein was not studied here, al-
though gene expression of IL-18R in IEC-6 cells was detected.
Thus, the production and release of IL-8 by IEC-6 after stim-
ulation with IL-18 suggest that these cells may be not only a
source of IL-18 but also a target for IL-18 actions. Interestingly,
the addition of exogenous IL-18 (10 ng/mL) to IEC-6 culture
exerts no effect on cellular proliferation, brush border enzyme
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activities, and gene expression of the proapoptotic and anti-
apoptotic markers Bax and Bcl-2.
In conclusion, these data show that IECs might be a target
for proinflammatory cytokines released by IEC themselves,
such as IL-18, as well as by proinflammatory cytokines released
by other mucosal cells, such as TNF- and IFN-. The ex-
pression of IL-18 and IL-18R mRNAs by normal differentiated
IEC points to the involvement of IL-18 in normal physiologic
processes.
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